Browse

Genetic immunotherapy of lung cancer using conditionally replicating adenovirus and adenovirus-interferon-beta

Cited 10 time in Web of Science Cited 10 time in Scopus
Authors
Park, M-Y; Kim, D. R.; Jung, H. W.; Yoon, H-I; Lee, C-T; Lee, J. H.
Issue Date
2010-05
Publisher
NATURE PUBLISHING GROUP
Citation
CANCER GENE THERAPY; Vol.17 5; 356-364
Keywords
conditionally replicating adenoviruslung cancergenetic immunotherapyadenovirus-IFN-beta
Abstract
Genetic immunotherapy is considered an ideal treatment modality for cancer because of its systemic nature. This study was designed to develop a potent novel genetic immunotherapy by combining conditionally replicating adenovirus (CRAd) and replication-defective adenovirus expressing interferon-beta (ad-IFN-beta). We investigated the efficacy of this therapy in an immunocompetent mouse tumor model. Transduction with CRAd (Delta 24RGD) induced cytolysis in a mouse lung cancer cell line (Lewis lung carcinoma (LLC)). Combined transduction of ad-IFN-beta and Delta 24RGD in the LLC cells induced a greater and more prolonged production of IFN-beta. Media transfer from the LLC-Delta 24RGD-ad-IFN-beta to untransduced LLC cells induced the production of IFN-beta; these results confirmed the replication and release of ad-IFN-beta. LLC cells transduced with ad-IFN-beta and Delta 24RGD had decreased tumorigenicity in syngeneic mice. Tumor vaccination with irradiated LLC-ad-IFN-beta-Delta 24RGD showed a significant increase in the survival of tumor-bearing syngeneic mice compared with mice with a single transduced LLC vaccination; this was mediated by an enhanced cytotoxic T-lymphocyte response against the LLC cells. The results of this study showed that cotransduced Delta 24RGD to ad-IFN-beta aided the replication of ad-IFN-beta in the LLC cells. A high local concentration of IFN-beta and local release of tumor antigen by CRAd induced strong antitumor immunity. This combination strategy might provide a powerful means by which ad-cytokines and CRAd can be combined and other adenoviruses expressing different cytokines might also be used. Cancer Gene Therapy (2010) 17, 356-364; doi:10.1038/cgt.2009.78; published online 6 November 2009
ISSN
0929-1903
Language
English
URI
http://hdl.handle.net/10371/76519
DOI
https://doi.org/10.1038/cgt.2009.78
Files in This Item:
There are no files associated with this item.
Appears in Collections:
College of Medicine/School of Medicine (의과대학/대학원)Internal Medicine (내과학전공)Journal Papers (저널논문_내과학전공)
  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse